A Nature Medicine study spanning six countries found AI models beat standard biomarkers at forecasting immunotherapy response in advanced lung…
The Toronto company raised a Series A co-led by OrbiMed and Qiming Venture Partners USA for AI that reads trial…
Flatiron Health's lung cancer dataset gains AI-extracted biomarker detail across more than 345,000 patients.
FDA clearance brings AI nodule planning and sharper navigation to J&J's Monarch lung biopsy robot.
New AI partnerships in oncology workflow and clinical decision support, plus a study on AI detecting missed lung cancers on…